Impact
A bigger and stronger platform
PharmChina compresses China’s drug channel decision-making into a short window when distributors finalize listings, pharmacy chains negotiate seasonal buys, and manufacturers scout partners. A strong Beijing edition ripples through provincial tenders and retail planograms for months. Missing the fair means relying on slower agent-led outreach while competitors capture face time with the accounts that still move most volume outside direct e-commerce.





